15 June 2022 - The NHS is set to roll out two ‘superbug’ busting drugs through a world first, pioneering subscription deal that will help tackle antimicrobial resistance, the head of the NHS announced today.
The deal, initially for two antimicrobial drugs, means patients with serious infections that have evolved so much that antibiotics and other current treatments are no longer effective, can be given a potentially life-saving alternative.